Determining the Efficacy of Full-time Occlusion Therapy in Severe Amblyopia at Different Ages

Sponsor
Mughal Eye Trust Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02113709
Collaborator
(none)
115
1
1
53
2.2

Study Details

Study Description

Brief Summary

Objective: To find out how much visual improvement is possible in severe amblyopia using full-time occlusion therapy with an eye patch and to see if improvement is influenced by the patient's age.

Methods: An interventional clinical trial of 115 consecutive cases with unilateral, severe amblyopia was conducted at a tertiary referral center from Jan 2010 to Oct 2012. Patients were divided into three age groups: 3-7 years (n= 38), 8-12 years (n=41), 13-35 years (n=36). After a complete ophthalmological examination by a single ophthalmologist, cases with organic visual loss were excluded; cases with previous part-time occlusion therapy that had failed were included in the study. Patients were given optimal refractive correction for a month, followed by full-time occlusion therapy along with near visual activities for 3-4 hours/day. The therapy was continued until maximum visual recovery was achieved (6/6 Snellen's). Therapy was gradually reduced and stopped. Patients were followed-up regularly for the next 18 months.

Condition or Disease Intervention/Treatment Phase
  • Device: Occlusion therapy by Eye Patch
  • Device: Occlusion therapy
N/A

Detailed Description

Amblyopia, ('blunt vision' in Ancient Greek), also known as lazy eye, is a visual deficiency in an eye that is otherwise physically normal, or that is greater than would be expected from any structural abnormalities of the eye. There are unsubstantiated beliefs that it is more difficult to treat amblyopia in older age groups, that children that have already received failed amblyopia therapy do not respond to treatment and that full-time occlusion therapy may result in occlusion (disuse) amblyopia of the good eye. The aim of this study was to assess whether these beliefs are true. Materials and methods This was a prospective, interventional clinical trial of 115 consecutive cases with unilateral, severe amblyopia conducted at a tertiary referral center in Lahore, Pakistan, from January 2010 to October 2012. Eligibility criteria included an age of over three years, visual acuity in the amblyopic eye from 6/60 Snellen's or even counting fingers only, visual acuity in the sound eye of 6/6. A complete ophthalmic examination was performed by only one ophthalmologist (SI). This included examining the fixation pattern of both eyes, presence or absence of a phoria or a tropia by a cover-uncover test, fundus examination and color vision using Ishihara color plates. Any case with an organic cause for visual loss was excluded from the study after a thorough ophthalmological examination. Assessment of visual acuity of either eye for both near and distance acuity (Snellen's and ETDRS charts) refraction and Best Corrected Visual Acuity (BCVA) was performed by a trained optician who was masked to the study and patient's demographics.

Study Design

Study Type:
Interventional
Actual Enrollment :
115 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Determining the Efficacy of Full-time Occlusion Therapy in Severe Amblyopia at All Ages
Study Start Date :
Jan 1, 2010
Actual Primary Completion Date :
Oct 1, 2012
Anticipated Study Completion Date :
Jun 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Visual improvement

To see how efficiently visual improvement occurs by Full-time Occlusion therapy with an eye patch in severe amblyopia.

Device: Occlusion therapy by Eye Patch
The good eye was occluded by a stick-on eye patch to stimulate the amblyopic eye and its neural connections to learn to see again.

Device: Occlusion therapy
To see how much improvement in visual acuity occurs by full-time occlusion therapy.
Other Names:
  • eye patch (commercially pre-packed)
  • Outcome Measures

    Primary Outcome Measures

    1. Visual Acuity improvement [3 months]

      Full-time occlusion therapy of good eye was performed for 2-3 months while closely monitoring the vision of both the good and the amblyopic eye. Vision was assessed by EDTRS Charts as well as Snellen's Chart.

    Secondary Outcome Measures

    1. improvement in stereopsis [1 year]

      as equal visual acuity is attained by both eyes, the stereopsis also improves. It was assessed by satandardized TNO plates with the patient wearing polarized glasses over their own corrective spectacles.

    Other Outcome Measures

    1. Does the patched good eye develop occlusion amblyopia [3 months]

      The vision of patched good eye was meticulously monitored to note the development of occlusion amblyopia

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • a visual acuity of 6/60 or 0.1-0.2 ETDRS in one eye and 6/6 or 1.0 ETDRS in the good eye

    • strabismic amblyopia

    • patients of any age were included.

    Exclusion Criteria:
    • structural damage to the eye (organic amblyopia)

    • ametropic amblyopia

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mughal Eye Trust Hospital Lahore Punjab Pakistan 54770

    Sponsors and Collaborators

    • Mughal Eye Trust Hospital

    Investigators

    • Principal Investigator: Sameera Irfan, FRCS, Mughal Eye Trust Hospital, Lahore, Pakistan

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr. Sameera Irfan, Consultant Ophthalmologist, Mughal Eye Trust Hospital
    ClinicalTrials.gov Identifier:
    NCT02113709
    Other Study ID Numbers:
    • SIrfanMEHT
    First Posted:
    Apr 15, 2014
    Last Update Posted:
    Apr 15, 2014
    Last Verified:
    Apr 1, 2014
    Keywords provided by Dr. Sameera Irfan, Consultant Ophthalmologist, Mughal Eye Trust Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 15, 2014